Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
Express News | Hologic Inc : Leerink Partners Raises Target Price to $95 From $90
Hologic's Q3 2024 Earnings: What to Expect
Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have?
Hologic (HOLX) Exceeds Market Returns: Some Facts to Consider
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
Hologic (NASDAQ:HOLX) has outperformed the market over the past 20 years by 6.31% on an annualized basis producing an average annual return of 14.81%. Currently, Hologic has a market capitalization
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
The Medical Instruments industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?
Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares maintained its current share price over the past couple of month on the NASDAQGS, with a relatively tight range of
S&P 500 Futures Flat In Premarket Trading; Wells Fargo, Hologic Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Meritage Homes Corp. (MTH) was up 5.8% in pre-
Hologic (HOLX) Outperforms Broader Market: What You Need to Know
Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying?
Hologic Is Maintained at In-Line by Evercore ISI Group
Hologic Is Maintained at In-Line by Evercore ISI Group
Evercore Maintains Hologic(HOLX.US) With Hold Rating, Raises Target Price to $76
Evercore analyst Vijay Kumar maintains $Hologic(HOLX.US)$ with a hold rating, and adjusts the target price from $73 to $76.According to TipRanks data, the analyst has a success rate of 47.4% and a tot
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024
Hologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release,
Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating
Hologic (HOLX) has an average outperform rating and a price target range of $70 to $95, according to analysts polled by Capital IQ.
Peering Into Hologic's Recent Short Interest
Hologic's (NYSE:HOLX) short percent of float has fallen 8.59% since its last report. The company recently reported that it has 4.64 million shares sold short, which is 2.98% of all regular shares that
Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says
Stephens initiated coverage on Hologic Inc (NASDAQ:HOLX), citing it as a major player in women's health, known for its consistent revenue growth, strong free cash flow, and attractive profit margins,
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Hologic Initiated at Overweight by Stephens & Co.
Hologic Initiated at Overweight by Stephens & Co.